在患有 situs inversus totalis 的患者身上进行完全三维内镜中 mitra 置换
Taro Kanamori, Shota Yamanaka1, Yohei Onga1
1Department of Cardiovascular Surgery, Kawaguchi Cardiovascular and Respiratory Hospital, 1-1-51, Maekawa, Kawaguchi, Saitama 333-0842, Japan.
Journal of surgical case reports
|September 17, 2024
概括
这份报告详细介绍了第一个完全3D内镜 mitra 置换 (MVR) 在患有 situs inversus totalis (SIT) 的患者身上,这是一个罕见的疾病. 这次成功的手术突显了在复杂的解剖病例中微创性MVR的可行性.
科学领域:
- 心血管外科心血管外科
- 遗传异常是一种先天性异常.
- 最少侵入性手术的方法
背景情况:
- 逆心心位 (SIT) 与右心心位是一种罕见的先天性疾病.
- 由于镜像解剖学,SIT提出了独特的外科手术挑战.
- 严重的功能性 mitrale 吐需要干预.
研究的目的:
- 报告SIT.患者的第一个完全3D内镜中枢置换术 (MVR) 的情况.
- 证明这种方法在复杂解剖学中的可行性和潜在益处.
主要方法:
- 一名75岁的女性患者患有SIT和严重的功能性心肌吐,接受了MVR.
- 采用了采用简化三端口系统的全3D内镜方法.
- 精心的手术前规划和手术内适应镜像解剖学是至关重要的.
主要成果:
- 完全3D内镜MVR手术成功完成.
- 简化的三端口系统和3D内镜使手术更容易.
- 患者复杂的镜像解剖学得到了有效的管理.
结论:
- 完全内镜MVR可用于SIT和心脏干部心脏病患者.
- 这种微创手术在复杂的先天性异常方面具有潜在的益处.
- 仔细规划和适应是SIT患者成功治疗的关键.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


